A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
Clinical trial NCT06733441 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06733441
- Sponsor
- Treeline Biosciences, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2026-11-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.